The mechanisms that ultimately trigger β-catenin cellular redistribution in advanced HCC remain unresolved, although the effect of orthovanadate treatment on β-catenin/E-cadherin interaction suggests that increased tyrosine phosphorylation represents an important mechanism to disrupt AJ complex stability. This evidence concerns the gene CDH1 and hepatocellular carcinoma.